TRAPPC6A

Across TCGA pan-cancer cohorts, TRAPPC6A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TRAPPC6A data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher TRAPPC6A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRAPPC6A expression acts as an unfavorable survival marker.

KIRC, LIHC, and COAD are the cancer types where TRAPPC6A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.244	0.810	.008	12	view →
LIHC	OS	Median	All	0.144	0.688	.013	9	view →
COAD	DFS	Median	All	0.118	0.556	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TRAPPC6A–KIRC (OS)

Open the KIRC breakdown →